Your browser doesn't support javascript.
loading
The Role of TKS5 in Chromosome Stability and Bladder Cancer Progression.
Wang, Wenya; Zheng, Xi; Azoitei, Anca; John, Axel; Zengerling, Friedemann; Wezel, Felix; Bolenz, Christian; Günes, Cagatay.
Affiliation
  • Wang W; Department of Urology, Ulm University Hospital, 89081 Ulm, Germany.
  • Zheng X; Department of Urology, Ulm University Hospital, 89081 Ulm, Germany.
  • Azoitei A; Department of Urology, Ulm University Hospital, 89081 Ulm, Germany.
  • John A; Department of Urology, Ulm University Hospital, 89081 Ulm, Germany.
  • Zengerling F; Department of Urology, Ulm University Hospital, 89081 Ulm, Germany.
  • Wezel F; Department of Urology, Ulm University Hospital, 89081 Ulm, Germany.
  • Bolenz C; Department of Urology, Ulm University Hospital, 89081 Ulm, Germany.
  • Günes C; Department of Urology, Ulm University Hospital, 89081 Ulm, Germany.
Int J Mol Sci ; 23(22)2022 Nov 18.
Article in En | MEDLINE | ID: mdl-36430759
ABSTRACT
TKS5 promotes invasion and migration through the formation of invadopodia in some tumour cells, and it also has an important physiological function in cell migration through podosome formation in various nontumour cells. To date, the role of TKS5 in urothelial cells, and its potential role in BC initiation and progression, has not yet been addressed. Moreover, the contribution of TKS5 to ploidy control and chromosome stability has not been reported in previous studies. Therefore, in the present study, we wished to address the following questions (i) Is TKS5 involved in the ploidy control of urothelial cells? (ii) What is the mechanism that leads to aneuploidy in response to TKS5 knockdown? (iii) Is TKS5 an oncogene or tumour-suppressor gene in the context of BC? (iv) Does TKS5 affect the proliferation, migration and invasion of BC cells? We assessed the gene and protein expressions via qPCR and Western blot analyses in a set of nontumour cell strains (Y235T, HBLAK and UROtsa) and a set of BC cell lines (RT4, T24, UMUC3 and J82). Following the shRNA knockdown in the TKS5-proficient cells and the ectopic TKS5 expression in the cell lines with low/absent TKS5 expression, we performed functional experiments, such as metaphase, invadopodia and gelatine degradation assays. Moreover, we determined the invasion and migration abilities of these genetically modified cells by using the Boyden chamber and wound-healing assays. The TKS5 expression was lower in the bladder cancer cell lines with higher invasive capacities (T24, UMUC3 and J82) compared to the nontumour cell lines from human ureter (Y235T, HBLAK and UROtsa) and the noninvasive BC cell line RT4. The reduced TKS5 expression in the Y235T cells resulted in augmented aneuploidy and impaired cell division. According to the Boyden chamber and wound-healing assays, TKS5 promotes the invasion and migration of bladder cancer cells. According to the present study, TKS5 regulates the migration and invasion processes of bladder cancer (BC) cell lines and plays an important role in genome stability.
Subject(s)
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Urinary Bladder Neoplasms Limits: Humans Language: En Journal: Int J Mol Sci Year: 2022 Type: Article Affiliation country: Germany

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Urinary Bladder Neoplasms Limits: Humans Language: En Journal: Int J Mol Sci Year: 2022 Type: Article Affiliation country: Germany